Twist Bioscience

Oradora

Dra. Emily Leproust

CEO | Twist Bioscience

La Dra. Emily Leproust obtuvo su doctorado en Química Orgánica de la Universidad de Houston y es la directora ejecutiva y fundadora de Twist Bioscience. Forma parte de la Junta Directiva de CM Life Sciences y es cofundadora de Petri, un acelerador para empresas emergentes a la vanguardia de la ingeniería y la biología. La Dra. Leproust tiene múltiples patentes, muchas de ellas sobre ADN sintético.

Enter Presenter 2 Header

Enter Presenter 2 Name

Enter Presenter 2 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 3 Header

Enter Presenter 3 Name

Enter Presenter 3 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 4 Header

Enter Presenter 4 Name

Enter Presenter 4 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 5 Header

Enter Presenter 5 Name

Enter Presenter 5 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 6 Header

Enter Presenter 6 Name

Enter Presenter 6 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Escribiendo el futuro con Twist Bioscience

Fecha & Hora

Descripción

Enter Details Header

Oradora

Enter Presenter 2 Header

Enter Presenter 3 Header

Enter Presenter 4 Header

Enter Presenter 5 Header

Enter Presenter 6 Header